Introduction
because most of the DNA is trapped in the pulmonary Gene therapy is a potential treatment modality for tissue and endothelial cells. 2 To target genes specifically patients affected by hereditary kidney diseases. Special to the kidney, an improved approach seems to be to inject features of renal physiology and cell biology, ie renal DNA-liposome complex directly into the kidney. To selblood flow, urine flow, filtration limits at the glomerular ect the most efficient route for gene delivery, we combasement membrane, and low turnover rate of tubular pared the expression of ␤-galactosidase by three different epithelial cells, make the delivery of genes to the tubules routes of liposome-mediated gene delivery to the kidney particularly difficult. in mice, ie intra-renal-pelvic, intra-renal-arterial and Liposome was first introduced by Felgner et al 1 as an intra-renal-parenchymal injections ( Figure 1 ). efficient DNA transfection reagent. This prototype liposome contains two lipid species, a cationic lipid, N(1-(2, 3-dioleyloxy)propyl)-N,N,trimethylammonium chloride
Results
(DOTMA), and a neutral phospholipid, dioleoyl phosphatidyl ethanolamine (DOPE). Zhu et al 2 have recently Intra-renal-pelvic injection shown that DOTMA/DOPE liposome effectively delivers Out of 15 mice which received intra-renal-pelvic injection DNA to a large number of organs after intravenous injecof pCMV␤gal-DOTMA-DOPE (Lipofectin; Life Technotion. As expected, the lung and spleen, with their large logies, Gaithersburg, MD, USA) complex, three died of macrophage populations, were excellent expressors.
surgical complications and two others had a leakage durAmong other organs, kidney was a high expressor, better ing injection. The rest of them recovered from the prothan heart and liver, although the expression in the kidcedure and were killed at intervals from day 3 to day 42 ney is only 5% of the lung. Since retroviral vectors require for evaluation of transfection efficiency. Figure 2b and a replicating cells for transduction and adenovirus based show the X-gal staining of frozen sections from an vectors tend to induce immune reactions, liposomeinjected and a contralateral noninjected kidney, respectmediated gene delivery system appears to be an ideal ively, harvested 3 days after injection. The right lower method for gene therapy targeted to the kidney. The corner of Figure 2b is the inner medullary area which intravenous route is not efficient for gene transfer shows no staining of ␤-galactosidase. The outer medulla was heavily stained with blue-green color, while the cortical region had patchy staining. In contrast, the contralateral kidney was not stained at all (Figure 2a) . medullary areas from a noninjected and injected kidney, A semi-quantitative analysis of histochemical study is summarized in Table 1 . Strong expression (3+ to 5+) was respectively, harvested 21 days after injection. Intense Xgal staining was observed in many tubular cells but not present in the outer medulla, and weaker expression in the cortex (1+ to 3+) and in the inner medulla (0 to 2+) in the interstitial or vascular components (Figure 2d ). Again, no staining was observed in the tubules of the up to 21 days. The expression of ␤-galactosidase after intra-renal-pelvic injection lasted up to 35 days, but noninjected kidney (Figure 2c ). 
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The grading system for X-gal staining was: 0, negative; 1+, 1-5% positive cells; 2+, 6-10%; 3+, 11-20%; 4+, 21-50%; and 5+, Ͼ50%.
started to reduce after 21 days. On days 28 and 35, the expression of ␤-galactosidase was limited to a small region of the outer medulla.
Intra-renal-arterial injection
Fifteen mice received intra-renal-arterial injection of pCMV␤gal-Lipofectin complex. Three died of surgical complications and six others showed ischemic changes with necrosis and fibrosis at the time of harvest. The remaining six mice had normal kidneys, as confirmed by routine histology study using hematoxylin-eosin staining. The expression of ␤-galactosidase was apparent in the cortex and outer medulla of the injected kidney. observed in the contralateral noninjected kidney. As shown in Table 2 , the cortex and outer medulla had strong expression of ␤-galactosidase, while the inner Table 2 Expression of ␤-galactosidase in the kidney after intramedulla had weak staining. The expression decreased renal-arterial injection of pCMV␤gal-Lipofectin complex after 3 weeks and was undetectable in 5 weeks.
Mouse Days after Cortex Outer Inner
Intra-renal-parenchymal injection injection medulla medulla
Five mice received multiple intra-renal-parenchymal injections of DNA-Lipofectin complex. There was no X-
gal staining 3 or 7 days after the injection (data not
shown). Hematoxylin-eosin staining of the renal sections
showed focal infiltration of inflammatory cells. 
Effects of liposome on gene transfer
To assess the effect of liposome on gene transfer in the
The grading system for X-gal staining was: 0, negative; 1+, 1-5% renal tubules, we injected naked plasmid in the same positive cells; 2+, 6-10%; 3+, 11-20%; 4+, 21-50%; and 5+, Ͼ50%.
fashion. Five mice received intra-renal-arterial injection and five received intra-renal-pelvic injection (10 g DNA per kidney). The injected kidneys were harvested on day 3 and day 7. There was no X-gal staining in either group and two received 200 g. Both showed focal areas of gene expression 3 days after injections. Figure 4 shows mulof animals suggesting that liposome is required for gene expression at the DNA dose used in our experiments.
tiple ␤-galactosidase-positive spots in the areas near and deeper than the injection site in a mouse which received We also assessed the effects of intraparenchymal injection of naked DNA. Two mice received 20 g plasmid, 200 g DNA. These areas were confined to the tubules in both cortical and medullary regions. Similar gene transfer tubular cells only. No ␤-galactosidase-transfected cells could be detected in glomeruli, vessels or interstitium. following direct injection of naked DNA has been reported in other organs such as muscle 3 and liver. 4 The To our knowledge, this is the first report of kidneytargeted, liposome-mediated gene transfer in mice. Simitransfection efficiency (Ͻ5%) of naked DNA (200 g) via intraparenchymal injection is much less than that of lipolar studies using retroviral or adenoviral vectors in rats have been reported previously. Bosch and co-workers 5 some-mediated gene transfer (10 g DNA) via intrarenal-pelvic or intra-renal-arterial injections (Tables 1  reported a successful transfer of lacZ gene into the rat proximal tubules with a retroviral vector only after injurand 2).
ing the kidney transiently with a nephrotoxic dose of folic acid treatment. This treatment stimulates the regenerAssessment of nephrotoxicity Blood urea nitrogen (BUN) level was measured at the ation of tubular cells which is necessitated by the fact that the majority of the adult renal tubular cells are in a time of death. The mean (±s.e.) BUN of normal mice was 24 ± 1.3 mg/dl (n = 5). The mice which received intraquiescent state, and retroviruses only transduce proliferating cells. Moullier et al 6 have demonstrated a transient renal-pelvic injection had an average BUN of 27 ± 1.4 mg/dl (n = 12), intra-renal-arterial injection, 30 ± 1.9 gene transfer (up to 2 weeks) into rat renal tubular cells in vivo using a replication-defective adenoviral vector. mg/dl (n = 12), and intra-renal-parenchymal injection, 25 ± 1.4 mg/dl (n = 5). Only the intra-renal-arterial group This was delivered both by renal artery perfusion and retrograde infusion via the ureter. The former approach had a trend of increasing BUN when compared with the control, but it was not statistically significant (P = 0.08).
resulted in low-level proximal tubular expression predominantly in the renal cortex, while the latter resulted When those mice with severe ischemic changes, which were apparently due to the complications of intra-renalin strong expression mainly in papillary tubular cells. In either case, the ␤-galactosidase-positive cells were limited arterial injection per se, were removed, the BUN (25 ± 1.6 mg/dl, n = 6) was not different from the control. These to tubular cells with no evidence of any gene transfer into glomerular and vascular structures, or interstitial comresults suggest that a successful gene transfer with DNALipofectin was not associated with any significant renal partments. More recently, Zhu and co-workers 7 reported that by injecting a replication-defective adenoviral vector damage.
into the renal artery and incubating the kidney in the cold, they were able to transfer a ␤-galactosidase reporter Discussion gene into the vasculature in normal rats and the vasculature and renal cysts in the Han:SPDR rats. The limitations, In the present study, we successfully transferred a however, of adenovirus-mediated gene transfer is that foreign gene into renal tubular epithelial cells with DNAthe expression is transient, primarily due to the host's Lipofectin complex via intra-renal-pelvic or intra-renalimmune responses which also limit repeated adminisarterial injections. Apparent expression was observed in tration of adenoviral vectors. short-term experiments (up to 21 days) with intense Liposomes have been used successfully for in vivo gene staining of ␤-galactosidase in the outer medulla, a weaker transfer. Previously, Zhu et al 2 demonstrated a prolonged staining in the cortex, and almost no staining in the inner medulla. Interestingly, gene transfer occurred in renal systemic gene expression after intravenous delivery of DNA-liposome complex in mice. Interestingly, the kidsomal (episomal) element where it can be transcribed and translated to produce the gene product. In all in vivo sysney shows significant expression of transgene, although the intensity is about 1/20th of that in the lung. Furthertems studied to date, DNA is gradually eliminated from the target cell resulting in a commensurate decrease in more, the expression in the kidney is limited to the endothelium. As mentioned earlier, our results of intra-renalthe level of gene expression over time. 11 Therefore, multiple injections would be necessary for the treatment of arterial injection showed expression only in the tubular cells. The discrepancy between the two studies may be hereditary or chronic diseases. Fortunately, unlike adenoviral vectors, liposomes are generally regarded as nondue to the difference in plasmids, delivery routes, or sizes of DNA-liposome complexes, or other reasons.
immunogenic. 11 The safety of the in vivo use of a variety of liposome preparations has been demonstrated in sevOur results indicate that both intra-renal-pelvic and intra-renal-arterial injections effectively deliver DNA to eral studies using experimental animals 12 and also in clinical trials. [13] [14] [15] The safety issue was also addressed in the renal tubules. In the former, most tubules in the outer medulla appeared to be transfected while the inner medour study as we demonstrated that BUN levels were within normal range after gene therapy and that there ullary cells were spared. The lack of staining in the inner medulla was somewhat unexpected because the inner were no histological abnormalities found in the injected kidney. These results indicate that direct administration medulla is the region exposed to the DNA-liposome first. This result is in contrast with the data shown by Moullier of DNA-lipofectin complex into the kidney is not associated with nephrotoxicity. et al, 6 who demonstrated high expression of ␤-galactosidase in the papilla/medulla using ureteral retrograde
In conclusion, we demonstrated that both intra-renalpelvic and intra-renal-arterial injection of DNA-Lipofecinfusion with a replication-defective adenoviral vector. Using a similar gene delivery system as described in this tin complex led to gene expression in the renal tubular cells. Intra-renal-pelvic injection is more feasible than communication, we have delivered a human carbonic anhydrase II (CAII) gene into CAII deficient mice in an intra-renal-arterial injection in our mouse model because of the difficulty associated with injecting an adequate effort to correct the renal tubular acidosis in those mice. 8 Interestingly, we observed a similar lack of immunohistoamount of DNA-liposome complex into the renal artery and also because of the high incidence of renal ischemic chemical staining of CAII protein in the inner medulla (unpublished data). Therefore, the different results are injury. However, in humans, catheterization could conveniently provide direct gene delivery to renal arteries or likely due to different gene delivery systems, ie lipofection used in our laboratory versus the adenoviral vector renal pelvis. Therefore, both intra-renal-pelvic and intrarenal-arterial infusions would be suitable routes for lipoused by Moullier's group. We speculate that the difference in microenvironment between the inner and outer some-mediated gene transfer targeted to renal tubular epithelial cells. medulla may affect the interactions between DNA and liposome, therefore preventing gene uptake by the papillary cells. Alternatively, the gene uptake in papillary cells
Materials and methods
may be the same as other tubular cells, however, the transgene was not expressed properly due to factors such Gene injection as the efficiency and specificity of the promoter, early
Normal male mice weighing 25-30 g were used for this degradation of DNA, and altered half-time of mRNA study. We used CMV␤gal plasmid which contains a proand/or protein synthesized from the transgene. The moter from cytomegalovirus and expresses bacterial ␤-intra-renal-artery injection in the mice is a rather difficult galactosidase when transfected into mammalian cells. 16 procedure. However, when the injections were successPlasmid (10 g) was mixed with 25 l of Lipofectin in ful, the expression of transgene was comparable to that 5% dextrose (final volume: 300 l) and the mixture was by intra-renal-pelvic injection. It is not clear how the given to mice via the following three different routes: DNA-liposome complexes enter into the tubular cells from the vasculature. Similar findings were reported with
(1) Intra-renal-pelvic injection: A midabdomen incision an adenoviral vector by Moullier et al. 6 Apparently, the was made under anesthesia with phenobarbital (0.06 basement membranes do not preclude transfection by mg/g body weight, i.p.). The left kidney was exposed adenoviral vectors or DNA-liposome complex of tubular and ureter and ureteropelvic junction were freed of conepithelial cells via the vascular route.
nective tissues and vascular structures. An aliquot of 300 In the present study, the outer medulla has the highest l of DNA-liposome mixture was injected using a 30 G expression of transgenes. There are some potential beneneedle within 1 min. A light pressure was held to prevent fits of expression in such a localized area ie, the outer leakage after withdrawal of the syringe for 5 min. medulla. For example, Bartter's syndrome is associated with mutations in either a potassium channel or the furo-(2) Intra-renal-arterial injection: The left renal artery was semide-sensitive Na/K/2Cl cotransporter of medullary isolated and clamped. Using a 30 G needle, 300 l DNAthick ascending limbs which are located in the outer medliposome mixture was directly infused in the left renal ulla. 9 Other hereditary renal diseases affecting this region artery within 1 min. The renal blood flow was re-estabare medullary cystic disease and familial juvenile nephlished 5 min after injection. ronophthisis. 10 Therefore, our approach potentially can be used to deliver therapeutic genes to the outer medulla (3) Intra-renal-parenchymal injection: The left kidney was isolated. Eight to 10 injections of DNA-liposome prepfor correction of these genetic defects.
Liposome-mediated gene transfer provides a finite peraration (3 g DNA each) into renal parenchyma were given. The incision was then closed after the kidney was iod of gene expression as shown in our studies and others. The administered DNA appears to reside transichecked for its homogenous reperfusion and mice were allowed to recover. ently in the nucleus of the target cell as an extrachromo-Fifteen mice were used in each intra-renal-pelvic or Nephrology in Orlando, Florida in October, 1994 and published in an abstract form. intra-renal-arterial group, and five mice in the intrarenal-parenchymal group. In addition, five, five, and four
